Impact of sacubitril/valsartan on atrial fibrillation burden in heart failure: a retrospective observational study.

Background: Sacubitril/valsartan (an angiotensin receptor‐neprilysin inhibitors [ARNI]) might improve atrial fibrillation (AF) condition, but its added value remains controversial. Aim: We aimed to analyse the effect of ARNI on AF burden. Method: We conducted a single‐centre, retrospective self‐cont...

Full description

Bibliographic Details
Published in:Journal of Pharmacy Practice & Research Vol. 55; no. 1; pp. 53 - 61
Main Authors: Barradas, Ana, de Almeida Fernandes, Diogo, Fonseca, Inês, António, Natália, Elvas, Luís, Gonçalves, Lino
Format: research tables/charts Journal Article
Published: Wiley-Blackwell Feb2025
Online Access:View this record in EBSCOhost